Helps Manage Messaging Platforms, Assure Swift Collaboration; Pharmaceutical Firms Attest to IT Teams' Unique Needs for Strong Email Analysis and Reporting Solutions
WELLESLEY MA January 23, 2006 - DYS Analytics, Inc., a privately held firm whose innovative products and services manage today's top messaging platforms, announced that strong sales during fiscal year 2005, including major deployments and projects at Novartis, have given DYS an expanded presence in the pharmaceutical industry. Six of the top 10 pharmaceutical firms in the US , plus other leading international pharmaceutical organizations such as Serono International S.A. and Schering AG, use DYS CONTROL! to optimize their email, IM and eMeetings collaboration services.
With DYS CONTROL!, pharmaceutical IT staff can better cope with the masses of collaborative data that flows throughout the organization during the drug development process. IT can best assure systems operate at peak service levels with lowest total cost of ownership (TCO). Accrued savings can then be allocated toward growing the business. With this efficient infrastructure, development groups have immediate access to critical knowledge and thereby gain competitive advantage. DYS is showcasing its latest CONTROL! solutions today at the Lotusphere show in Orlando in its booth #611.
Pharmaceutical firms rely extensively on collaborative databases, emails, IM conversations and eMeetings to share knowledge efficiently between colleagues and accelerate projects. These collaborative applications must operate flawlessly 7/24 and operate at optimum performance levels or project goals are missed. Yet many pharmaceutical firms' networks have become so large and complex that IT teams are frequently delayed in discovering root causes, cannot swiftly find and correct misuse/abuse that slows performance for all, or are hampered in accurately planning future infrastructure needs.
Leading pharmaceutical firms who have purchased DYS' CONTROL! have found their IT staff now can:
Profile Email/IM Usage, Optimize Server Placement
One DYS Pharmaceutical customer uses CONTROL! to profile email usage, develop policies and best practices and ensure ongoing compliance with these policies. This helps reduce the amount of email sent - imposing less burden on the infrastructure and less burden on the recipients to filter through unnecessary messages.
In another instance, a Pharmaceutical firm halted deployment of additional IBM Lotus Sametime servers in one country when DYS CONTROL! uncovered low Sametime IM traffic there and far greater demand for these services in the US. By locating the additional servers in the US, the firm lowered international WAN costs and ensured optimal Sametime performance in the areas of greatest need - especially as Sametime real-time audio conferencing was being used.
"Pharmaceutical firms are such heavy users of Domino applications, email and IM, that it's easy for their networks to become overrun with traffic that exceeds available CPU, storage and bandwidth capacity," said Andrew Wolff, vice president of products, DYS Analytics. "DYS Analytics helps these firms ensure their messaging and application networks are both high performing and operating at lowest cost."
DYS CONTROL! solutions provide IT managers at pharmaceutical organizations with a deep understanding of their email, instant messaging, e-Meeting and application databases use. Using CONTROL!, IT staff analyze, are alerted on health/availability issues, obtain metric reports on enterprise-wide collaborative application use such as IBM Lotus Notes, Microsoft Exchange, IBM Lotus Sametime and IBM Lotus QuickPlace. Armed with these metrics, IT professionals accelerate strategic projects like platform upgrades, server consolidations, topology redesigns and merger/acquisition-related network changes. By having a complete picture of their traffic, usage and performance, IT staff proactively manage their network, dramatically reduce operational costs and improve messaging performance levels.
###